FirmAtlas
Company handbook · COR · Prepared by FirmAtlas · firmatlas.app · printed 2026-10-16
COR · CIK 1140859 · LATEST FILING: 10-Q JUN '26 · FILED AUG 5, 2026
CENCORA, INC.
$340.92
−0.49 (−0.14%)
Close, Oct 16, 2026 · 52-week $245–378
Last fiscal year
CENCORA, INC. reported revenue of $321.3B for the year ended Sep 30, 2025 (FY25), up 9.3% from FY24. Net income was $1.6B, operating cash flow $3.9B and free cash flow $3.2B. Source: 10-K filed Nov 25, 2025.
Market cap
$66.1B
P/E
25.2
EV/EBITDA
18.9x
P/B
21.7
Div yield
0.70%
ROIC
56.1%
Revenue 1Y
9.3%/yr
EPS 1Y
5.7%/yr
Shares 1Y
−0.5%
Loading chart…
Median
Daily closes, split-adjusted · ratios at each fiscal year end
Company
CEORobert P. Mauch
HQConshohocken, PA
AuditorErnst & Young LLP
Employees51,000
Year endsSeptember
Revenue by segment · FY25
US Healthcare Solutions91%
International Healthcare Solutions9%
Compounded growth & averages
10Y
5Y
3Y
TTM
Share price
15.6%
23.3%
22.2%
6.7%
Upgrade to see 10 years
Share price: yearly compound rate of the traded close; the last column is the past year.
Where the cash went · FY24–FY25
$8.1B deployed
Capex
$1.2B
14.3%
Acquisitions
$4.2B
51.4%
Dividends
$853M
10.5%
Buybacks
$1.9B
23.8%
Operating cash flow over the period: $7.4B. Total debt changed by +$3.3B.
Growth engines
How much of the profit growth came from new investment, and how much from running the business better.
Upgrade to see 10 years
Financials
Last 2 years · Upgrade to see 10 years · USD millions · each year opens its 10-K · FY25 = year ended Sep 30, 2025 · change vs previous year
Last 4 quarters · USD millions · quarter-end month shown · change vs same quarter a year earlier
TTM = the last four quarters, to Jun '26. Balance-sheet rows show that latest quarter. “—” where the quarters do not add up to the annual figures. No TTM for cash: our quarterly rows do not hold short-term investments yet, and annual cash includes them.
Income
Revenue
293,959
321,333+9.3%
332,771
YoY
+9.3%
Gross profit
9,910
11,479+15.8%
13,221
Gross margin
3.4%
3.6%+0.2 pp
—
Operating income
2,175
2,629+20.8%
3,042
Operating margin
0.7%
0.8%+0.1 pp
—
EBITDA
3,267
3,680+12.6%
—
EBITDA margin
1.1%
1.1%+0.0 pp
—
Interest expense
250
356+42.5%
—
Interest coverage
13.06x
10.32x−2.74x
—
Net income
1,509
1,554+3.0%
2,625
YoY
+3.0%
Net margin
0.5%
0.5%−0.0 pp
—
EPS (diluted, $)
7.53
7.96+5.7%
13.46
YoY
+5.7%
Balance sheet
Total assets
67,102
76,590+14.1%
83,806
Cash & short-term investments
3,298
4,395+33.3%
—
Accounts receivable
23,872
25,225+5.7%
—
Inventory
18,999
20,492+7.9%
—
Net PP&E
2,181
2,539+16.4%
—
Other assets
18,752
23,939+27.7%
—
Total liabilities
66,456
75,082+13.0%
80,755
Accounts payable
50,942
54,720+7.4%
—
Total debt
4,388
7,661+74.6%
11,723
Other liabilities
11,125
12,702+14.2%
—
Shareholders’ equity
646
1,508+133.5%
3,051
Total liabilities = total assets − shareholders’ equity, so it includes minority interest where a company has one.
Cash flow statement · as filed
Cash from operations
3,485
3,875+11.2%
4,821
Net income
1,519
1,568+3.2%
—
Depreciation & amortization
1,092
1,051−3.7%
—
Stock-based compensation
148
148−0.0%
—
Working capital & other
725
1,108+52.8%
—
Cash from investing
(618)
(4,977)n/m
—
Capex
(487)
(668)n/m
—
Acquisitions
(70)
(4,096)n/m
—
Other investing
(61)
(214)n/m
—
Cash from financing
(2,331)
2,249n/m
—
Debt raised
688
4,508+555.0%
—
Debt repaid
(663)
(1,281)n/m
—
Dividends
(416)
(437)n/m
—
Buybacks
(1,491)
(435)n/m
—
Shares issued
38
29−23.0%
—
Other financing
(487)
(135)n/m
—
Net change in cash
545
1,097+101.2%
—
Free cash flow (OCF − capex)
2,998
3,207+7.0%
4,060
Where the cash went
Operating cash flow
3,485
3,875+11.2%
4,821
Reinvested in the business
557
4,764+755.3%
—
% of operating cash flow
16.0%
122.9%
Capex
487
668+37.1%
761
Acquisitions
70
4,096+5770.1%
—
Free cash flow
2,998
3,207+7.0%
4,060
YoY
+7.0%
Returned to shareholders
1,908
873−54.3%
—
% of free cash flow
63.6%
27.2%
Dividends
416
437+5.0%
—
Buybacks
1,491
435−70.8%
—
Change in total debt
—
3,273
—
Cash left over
—
1,512
—
FCF conversion (FCF ÷ net income)
198.6%
206.4%+7.7 pp
—
Owner earnings
—
2,868
—
Owner earnings margin
—
0.9%
—
Buyback yield
3.4%
0.7%−2.7 pp
—
Returns & ratios
ROIC (all capital)
95.0%
56.1%−38.9 pp
—
Net debt / EBITDA
0.33x
0.89x+0.55x
—
Debt / equity
6.79x
5.08x−1.71x
—
Cash conversion cycle (days)
−11
−12−0 d
—
ROE
233.6%
103.1%−130.6 pp
—
ROA
2.2%
2.0%−0.2 pp
—
ROCE
17.0%
14.0%−3.0 pp
—
NOPAT
1,649
1,825+10.7%
—
Invested capital (operating)
(5,890)
(6,463)n/m
—
Invested capital (all)
1,736
4,774+175.0%
—
Reinvestment rate
—
−31.4%
—
Debtor days
30
29−1 d
—
Inventory days
24
24−0 d
—
Days payable
65
64−1 d
—
Income
Sep '25
Dec '25
Mar '26
Jun '26
Revenue
83,729
85,932
78,356
84,755
vs year-ago quarter
Gross profit
2,954
3,072
3,588
3,607
Gross margin
3.5%
3.6%
4.6%
4.3%
Operating income
19
760
1,143
1,120
Net income
(340)
560
1,641
764
vs year-ago quarter
Net margin
−0.4%
0.7%
2.1%
0.9%
EPS (diluted, $)
−1.75
2.87
8.40
3.94
vs year-ago quarter
Balance sheet
Sep '25
Dec '25
Mar '26
Jun '26
Total assets
76,590
78,361
81,652
83,806
Cash & equivalents
4,395
1,809
2,236
2,865
Total debt
7,661
7,922
12,386
11,723
Shareholders’ equity
1,508
1,908
3,398
3,051
Cash flow
Sep '25
Dec '25
Mar '26
Jun '26
Operating cash flow
3,133
(2,305)
1,339
2,654
Capex
250
119
166
226
Free cash flow
2,884
(2,425)
1,173
2,428
vs year-ago quarter